$421.39
-1.24-0.29%
In chiusura: -
$421.39
0.000.00%
After hour: 4:00 PM EDT
Il short interest su Vertex Pharmaceuticals Inc (NASDAQ:VRTX) è diminuito durante l'ultimo periodo di rilevazione, aumentando da 4.05M a 3.56M. Questo rappresenta il 1.56% delle azioni disponibili pubblicamente dell'azienda.
L'interesse allo scoperto in Vertex Pharmaceuticals Corp (XNAS:VRTX) è diminuito durante l'ultimo periodo di rendicontazione, passando da 280,30 milioni a 275,20 milioni. Ciò ha portato allo scoperto l'1,17% delle azioni pubbliche della società.
Sulla base del volume medio recente di 2.03M azioni scambiate al giorno, ci vorrebbero 1.75 giorno(i) per chiudere le posizioni di questo interesse a breve senza spingere fortemente al rialzo il titolo.
Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|
VRTX | Vertex Pharmaceuticals Incorpo | 09/30/2025 | 10/09/2025 | 1.56% | 227,369,501 | 3,557,058 | 2,027,132 | 1.75 | |
VRTX | Vertex Pharmaceuticals Incorpo | 09/15/2025 | 09/24/2025 | 1.78% | 227,369,501 | 4,053,668 | 1,277,924 | 3.17 | |
VRTX | Vertex Pharmaceuticals Incorpo | 08/29/2025 | 09/10/2025 | 1.60% | 227,369,501 | 3,639,292 | 1,570,284 | 2.32 | |
VRTX | Vertex Pharmaceuticals Incorpo | 08/15/2025 | 08/26/2025 | 1.63% | 227,369,501 | 3,700,693 | 3,340,013 | 1.11 | |
VRTX | Vertex Pharmaceuticals Incorpo | 07/31/2025 | 08/11/2025 | 1.92% | 227,369,501 | 4,362,540 | 1,119,318 | 3.9 | |
VRTX | Vertex Pharmaceuticals Incorpo | 07/15/2025 | 07/24/2025 | 1.84% | 227,776,037 | 4,188,160 | 1,007,188 | 4.16 | |
VRTX | Vertex Pharmaceuticals Incorpo | 06/30/2025 | 07/10/2025 | 1.93% | 227,776,037 | 4,389,791 | 1,480,514 | 2.97 | |
VRTX | Vertex Pharmaceuticals Incorpo | 06/13/2025 | 06/25/2025 | 1.77% | 227,776,037 | 4,034,849 | 1,124,521 | 3.59 | |
VRTX | Vertex Pharmaceuticals Incorpo | 05/30/2025 | 06/10/2025 | 1.94% | 227,776,037 | 4,408,560 | 1,525,051 | 2.89 | |
VRTX | Vertex Pharmaceuticals Incorpo | 05/15/2025 | 05/27/2025 | 2.12% | 227,776,037 | 4,824,964 | 2,700,418 | 1.79 | |
VRTX | Vertex Pharmaceuticals Incorpo | 04/30/2025 | 05/09/2025 | 1.66% | 227,776,037 | 3,780,307 | 1,319,341 | 2.87 | |
VRTX | Vertex Pharmaceuticals Incorpo | 04/15/2025 | 04/25/2025 | 1.70% | 256,532,900 | 4,371,605 | 1,951,981 | 2.24 | |
VRTX | Vertex Pharmaceuticals Incorpo | 03/31/2025 | 04/09/2025 | 1.74% | 256,532,900 | 4,463,380 | 1,369,986 | 3.26 | |
VRTX | Vertex Pharmaceuticals Incorpo | 03/14/2025 | 03/25/2025 | 2.24% | 256,532,900 | 5,753,349 | 1,362,654 | 4.22 | |
VRTX | Vertex Pharmaceuticals Incorpo | 02/28/2025 | 03/11/2025 | 2.14% | 256,532,900 | 5,484,026 | 1,395,128 | 3.93 | |
VRTX | Vertex Pharmaceuticals Incorpo | 02/14/2025 | 02/26/2025 | 1.98% | 256,532,900 | 5,066,603 | 1,459,354 | 3.47 | |
VRTX | Vertex Pharmaceuticals Incorpo | 01/31/2025 | 02/11/2025 | 1.77% | 257,272,321 | 4,561,796 | 1,589,768 | 2.87 | |
VRTX | Vertex Pharmaceuticals Incorpo | 01/15/2025 | 01/27/2025 | 1.71% | 257,272,321 | 4,394,404 | 1,538,051 | 2.86 | |
VRTX | Vertex Pharmaceuticals Incorpo | 12/31/2024 | 01/10/2025 | 1.54% | 257,272,321 | 3,955,628 | 2,473,678 | 1.6 | |
VRTX | Vertex Pharmaceuticals Incorpo | 12/13/2024 | 12/24/2024 | 1.37% | 257,272,321 | 3,512,605 | 1,076,276 | 3.26 | |
VRTX | Vertex Pharmaceuticals Incorpo | 11/29/2024 | 12/10/2024 | 1.43% | 257,272,321 | 3,671,223 | 1,425,519 | 2.58 | |
VRTX | Vertex Pharmaceuticals Incorpo | 11/15/2024 | 11/26/2024 | 1.60% | 257,272,321 | 4,110,712 | 1,421,813 | 2.89 | |
VRTX | Vertex Pharmaceuticals Incorpo | 10/31/2024 | 11/11/2024 | 1.75% | 257,272,321 | 4,504,708 | 995,692 | 4.52 | |
VRTX | Vertex Pharmaceuticals Incorpo | 10/15/2024 | 10/24/2024 | 1.66% | 257,845,234 | 4,291,428 | 993,680 | 4.32 | |
VRTX | Vertex Pharmaceuticals Incorpo | 09/30/2024 | 10/09/2024 | 1.58% | 257,845,234 | 4,076,349 | 1,046,356 | 3.9 | |
VRTX | Vertex Pharmaceuticals Incorpo | 09/13/2024 | 09/24/2024 | 1.68% | 257,845,234 | 4,335,229 | 927,790 | 4.67 | |
VRTX | Vertex Pharmaceuticals Incorpo | 08/30/2024 | 09/11/2024 | 1.70% | 257,845,234 | 4,380,989 | 1,017,142 | 4.31 | |
VRTX | Vertex Pharmaceuticals Incorpo | 07/31/2024 | 08/09/2024 | 1.97% | 257,845,234 | 5,080,317 | 1,089,764 | 4.66 | |
VRTX | Vertex Pharmaceuticals Incorpo | 07/15/2024 | 07/24/2024 | 1.60% | 257,796,418 | 4,124,520 | 818,649 | 5.04 | |
VRTX | Vertex Pharmaceuticals Incorpo | 06/28/2024 | 07/10/2024 | 1.59% | 257,796,418 | 4,102,631 | 1,590,794 | 2.58 | |
VRTX | Vertex Pharmaceuticals Incorpo | 06/14/2024 | 06/26/2024 | 1.73% | 257,796,418 | 4,466,815 | 1,110,240 | 4.02 | |
VRTX | Vertex Pharmaceuticals Incorpo | 05/31/2024 | 06/11/2024 | 1.69% | 257,796,418 | 4,348,066 | 1,229,301 | 3.54 | |
VRTX | Vertex Pharmaceuticals Incorpo | 05/15/2024 | 05/24/2024 | 1.46% | 257,796,418 | 3,769,903 | 1,134,597 | 3.32 | |
VRTX | Vertex Pharmaceuticals Incorpo | 04/30/2024 | 05/09/2024 | 1.50% | 257,796,418 | 3,871,329 | 976,621 | 3.96 | |
VRTX | Vertex Pharmaceuticals Incorpo | 04/15/2024 | 04/24/2024 | 1.56% | 258,202,374 | 4,029,234 | 918,144 | 4.39 | |
VRTX | Vertex Pharmaceuticals Incorpo | 03/28/2024 | 04/09/2024 | 1.54% | 258,202,374 | 3,975,531 | 874,716 | 4.54 | |
VRTX | Vertex Pharmaceuticals Incorpo | 03/15/2024 | 03/26/2024 | 1.60% | 258,004,125 | 4,125,172 | 1,089,177 | 3.79 | |
VRTX | Vertex Pharmaceuticals Incorpo | 02/29/2024 | 03/11/2024 | 1.57% | 258,004,125 | 4,054,715 | 1,024,051 | 3.96 | |
VRTX | Vertex Pharmaceuticals Incorpo | 01/31/2024 | 02/09/2024 | 1.28% | 257,379,493 | 3,307,184 | 1,662,247 | 1.99 | |
VRTX | Vertex Pharmaceuticals Incorpo | 01/12/2024 | 01/24/2024 | 1.30% | 257,379,493 | 3,353,775 | 1,207,989 | 2.78 | |
VRTX | Vertex Pharmaceuticals Incorpo | 12/29/2023 | 01/10/2024 | 1.27% | 257,379,493 | 3,256,021 | 941,024 | 3.46 | |
VRTX | Vertex Pharmaceuticals Incorpo | 12/15/2023 | 12/27/2023 | 1.38% | 257,379,493 | 3,551,776 | 2,034,003 | 1.75 | |
VRTX | Vertex Pharmaceuticals Incorpo | 11/30/2023 | 12/11/2023 | 1.04% | 257,379,493 | 2,687,898 | 1,478,893 | 1.82 | |
VRTX | Vertex Pharmaceuticals Incorpo | 11/15/2023 | 11/27/2023 | 0.97% | 257,379,493 | 2,507,003 | 1,528,993 | 1.64 | |
VRTX | Vertex Pharmaceuticals Incorpo | 10/31/2023 | 11/09/2023 | 1.01% | 257,379,493 | 2,604,104 | 1,248,426 | 2.09 |
In cerca di azioni più vendute allo scoperto?